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Introduction. In the Republic of Moldova, the first case of COVID-19 was confirmed on 
March 7, followed by a significantly increasing incidence across the country. It is im-
portant to describe the clinical and epidemiological aspects that were adjusted to the 
national context in order to develop and implement optimal public health care measures. 
Material and methods. A cross-sectional descriptive study was conducted from March 7 
to April 6, 2020, using the surveillance system data of the Republic of Moldova on COVID-
19 case incidence. All cases of COVID-19 were confirmed by Real-Time PCR. 
Results. During the reference period, 965 cases of COVID-19 were registered, whereas the 
urban incidence rate was 1.4 times higher than the rural one. The mean age of infected 
population was 45.2 years, whereas the most affected age group was 50-59 years, found 
in 232 cases. Healthcare workers made up 26.6±1.4% out of 965 diseased patients.  They 
included nurses – 34.2±3.0%, auxiliary medical staff – 29.6±2.8%, doctors – 27.2±2.8%, 
first-aid assistants – 7.4±1.6%, pharmacists – 1.2±0.7%, paramedics – 0.4±0.4%. The 
health status of people diagnosed with COVID-19 was severe in 8.0±0.9% of cases; mod-
erate severity – in 34.7±1.5% and satisfactorily severe – in 57.3±1.6% of cases.  
Conclusions. The identified clinical and epidemiological aspects allowed readjusting the 
public health policies in order to prevent the spread of COVID-19 infection among the 
elderly and medical workers.  
Cuvinte cheie:         
COVID-19, infecție, 
Republica Moldova, 
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EPIDEMIOLOGIA INFECȚIEI CU NOUL TIP DE CORONAVIRUS (COVID-19) ÎN           
PERIOADA INIȚIALĂ A PANDEMIEI ÎN REPUBLICA MOLDOVA  
Introducere. Primul caz de infectare cu noul tip de coronavirus COVID-19 în Republica 
Moldova a fost confirmat la data de 7 martie 2020, ulterior a fost înregistrată o creștere 
semnificativă a îmbolnăvirilor. Aspectele clinico-epidemiologice ajustate contextului 
național sunt necesare a fi descrise pentru elaborarea și implementarea acțiunilor op-
time de sănătate publică. 
Material și metode. Am realizat un studiu descriptiv transversal în perioada 7.03.2020 – 
6.04.2020, folosind datele din sistemul de supraveghere a Republicii Moldova cu privire la 
cazurile de infecție COVID-19, care au fost confirmate prin tehnici de biologie moleculară 
(Real-Time PCR).  
Rezultate. În perioada de referință au fost înregistrate 965 cazuri de COVID-19, mediul 
urban fiind afectat de 1,4 ori mai mult decât cel rural. Vârsta medie a celor infectați a 
fost de 45,2 ani, iar cel mai afectat grup de vârstă a fost cel de 50-59 ani – 232 cazuri. 
Dintre cele 965 persoane infectate, lucrătorii medicali reprezintă 26,6±1,4%: asistenți 
medicali – 34,2±3,0%; personal medical auxiliar – 29,6±2,8%; medici – 27,2±2,8%; felceri 
– 7,4±1,6%; farmaciști – 1,2±0,7%; paramedici – 0,4±0,4%. Starea de sănătate a per-
soanelor diagnosticate cu COVID-19 a fost gravă în 8,0±0,9%, de gravitate medie în 
34,7±1,5% și satisfăcătoare în 57,3±1,6%. 
Concluzii. Aspectele clinico-epidemiologice identificate permit reajustarea politicelor de 
sănătate publică referitor la prevenirea răspândirii infecției COVID-19 printre persoanele 
în vârstă și lucrătorii medicali.  
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INTRODUCTION 
Coronavirus belongs to a large family of viruses 
that can cause various symptoms such as pneu-
monia, fever, shortness of breath and lung infec-
tion (1). These viruses are common in animals 
around the world but are known to affect hu-
mans in some cases. Although coronaviruses are 
a large family of viruses, it is considered that 
only six (229E, NL63, OC43, HKU1, MERS-CoV, 
and SARS-CoV) could infect humans. Thus, 2019-
CoV became the seventh (2, 3). 
The World Health Organization (WHO) used the 
term new coronavirus 2019 to refer to a corona-
virus that affected the lower respiratory tract of 
patients with pneumonia in Wuhan, China, on 
December 29, 2019 (4, 5, 6). The WHO has an-
nounced that the official name of the new type of 
coronavirus in 2019 is COVID-19 – coronavirus 
disease (6). 
And the current reference name for the virus is 
Severe Acute Respiratory Syndrome Corona-
virus-2 (SARS-CoV-2). This is a single-stranded 
RNA coronavirus with positive polarity. The vi-
rus underwent a genomic sequence, following 
the nucleic acid testing on specimens from a pa-
tient with pneumonia during the 2019-2020 
Wuhan coronavirus epidemic. Wuhan beta-coro-
navirus sequences have similarities to the beta-
coronaviruses identified in bats. However, the 
virus is genetically distinct from other corona-
viruses, such as SARS-CoV and MERS-CoV (7). 
At the end of December 2019, a group of patients 
was hospitalized with an initial diagnosis of 
pneumonia with an unknown etiology. These 
patients have been epidemiologically related to a 
seafood and wet animals wholesale market in 
Wuhan, Hubei Province, China (8). Early reports 
predicted the emergence of a potential Coro-
navirus outbreak, by estimating the repro-
duction number of the novel Coronavirus 
(COVID-19, named by the WHO on 11 February 
2020) as being significantly higher than 1 (inter-
vals from 2.24 to 3.58) (9). 
By April 6, 2020, more than 134,901 people were 
infected worldwide, by affecting almost every 
country across the globe. Moreover, at the bein-
ning of April, the mortality rate was calculated in 
the following countries like Germany, this index 
being of 1.2%, compared to Italy – 11.9%, Spain 
– 8.6%, the Netherlands – 8%, the United King-
dom – 7.1% and France – 9.0% (10, 11). Howev-
er, the overall mortality rate accounted for 2.2-
3.4% (12). 
Globally, about 3.4% of reported COVID-19 cases 
have died. By comparison, seasonal flu generally 
kills much less than 1% of those infected (13, 
14). Virus susceptibility appears to be associated 
with age, gender and other health conditions 
(15). COVID-19 has now been declared by the 
WHO as public health emergency of international 
concern (16). 
Due to the rapid spread of the new coronavirus 
and its effects on human health, the scientific 
community responded quickly to the new virus 
and many early research studies have already 
been published on this epidemic (9-14). This 
article is aimed to provide information and evi-
dence on the evolution of the COVID-19 epidemic 
in the Republic of Moldova at its initial stage. 
This article can provide meaningful information 
for future research on this topic and justify the 
governmental decision-making on management 
strategies regarding this public health emergen-
cy at both community and national level. The 
combination of epidemiological data can provide 
an early understanding of the pandemic situa-
tion, thus promoting a balanced and well-
targeted action from public health perspective. 
 
MATERIAL AND METHODS 
The present cross-sectional descriptive study 
was conducted from March 7 – April 6, 2020. The 
national surveillance system data of the Republic 
of Moldova have been reported cases based on 
standard case definition, namely, COVID-19 sus-
pected, possible or confirmed cases during the i-
nitial stage of the epidemic. All cases of COVID-
19 were confirmed via molecular biology (Real-
Time PCR) techniques. The confirmed case defi-
nition was used according to the national legisla-
tion in force, namely "A person with laboratory 
confirmation of COVID-19 infection, regardless 
of clinical signs and symptoms." The statistical 
data have been processed via MicrosoftExcel and 
EpiInfo 7.2. 
 
RESULTS  
The first suspected COVID-19 case in the Republic 
of Moldova was reported on March 7, fol lowed 
by laboratory confirmation on 08 March in a 
person who entered the country. In the following 
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week, there was a steady increasing daily ten-
dency, with unique cases being registered. A 
constant increase in the number of cases were 
reported over the next 2 weeks, viz. tens of new-
ly-infected people per day, so that over the last 
week there was a sudden increase in the number 
of cases, being estimated to around 100 cases 
per day. On April 6.965 cases were registered, 
whereas 101 cases had been reported a day be-
fore (fig. 1). 
 
 
 
Figure 1. Number of new and cumulative cases of COVID-19 reported in the Republic of  
Moldova during the reference period (abs.). 
 
However, along with the increasing number 
COVID-19 cases, various laboratory diagnostic 
activities were conducted in this regard (fig. 2). 
The present data confirms that according to the 
case definition for COVID-19 infection, a signi-
fycant number of people underwent testing. The 
number of investigations was continuously in-
creasing until April 4, 2020, when it was at high-
est, when 681 investigated samples were per-
formed. Afterwards on April 5 and 6, the number 
of tests decreased, more likely because these 
were the weekend days. It should be mentioned 
that an overall number of 4,598 tests have been 
performed so far, within the Virology laboratory 
of NAPH. 
The geographical distribution of COVID-19 cases 
was also assessed, in order to identify the virus 
spreading intensity. Therefore, on April 6, 2020, 
almost all the administrative territories of the 
country were affected, except for Soldanesti and 
Rezina districts. 
The highest levels of COVID-19 incidence were 
recorded in the following regions: Ștefan Vodă – 
213.27o/oooo  (148 cases),  Soroca  –  125.73o/oooo  
(125 cases), and Glodeni – 61.34o/oooo (36 cases). 
A high incidence rate was found in Chisinau – 
37.94o/oooo (316 cases). As regarding the geo-
graphical distribution, the most affected were 
the Southern areas – 41.64o/oooo (219 cases), 
followed by the Northern areas – 37.94o/oooo 
(222 cases), and the Central areas – 14.51o/oooo 
(152 cases). The incidence rate in the adminis-
trative territories with special status, namely, 
ATU Gagauzia was 1.24o/oooo (2 cases), and 
Transnistria – 11.53o/oooo (54 cases) (tab. 1). 
Therefore, the major outbreaks registered at this 
stage of the epidemic, also called as community 
transmission, occurred mainly in Chisinau, and 
Soroca and Stefan-Voda districts. The massive 
spread of disease was reported in Glodeni dis-
trict. 
During the initial period of the epidemic, the 
total number of people infected with the novel 
coronavirus accounted for 385 patients from 
rural areas and 539 patients from urban areas. 
Therefore, the incidence rate made up 
41.7±1.6% cases – rural areas and 58.3±1.6% – 
urban areas, respectively.  This phenomenon is 
probably  due  to  the  massive  internal and exter   
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nal migration of people from urban areas, as well 
as due to a higher contact level among people in 
places with high population density and urban 
activities associated with people behavior and 
mass-gathering (fig. 3). 
 
 
 
Figure. 2. Number of persons tested and found positive to COVID-19 in the Republic of Moldova, during 
the reference period (abs.). 
 
Table 1. Geographical distribution of COVID-19 cases in the early stages of the epidemic in the  
Republic of Moldova (abs. and o/oooo). 
 
Administrative territory Number of population Number of cases Incidence 
Chisinau 832,865 316 37.94 
Northern areas 974,558 222 22.78 
Balti 151,791 10 6.59 
Briceni 71,447 4 5.60 
Donduseni 41,719 1 2.40 
Drochia 85,558 2 2.34 
Edinet 79,160 5 6.32 
Falesti 90,275 20 22.15 
Floresti 85,643 2 2.34 
Glodeni 58,691 36 61.34 
Ocnita 52,948 1 1.89 
Riscani 66,498 5 7.52 
Singerei 91,412 11 12.03 
Soroca 99,416 125 125.73 
Central areas 1,047,681 152 14.51 
Anenii Noi 82,998 12 14.46 
Calarasi 76,551 4 5.23 
Criuleni 73,371 6 8.18 
Dubasari 34,969 1 2.86 
Hincesti 118,619 32 26.98 
Ialoveni 101,797 36 35.36 
Nisporeni 64,797 10 15.43 
Orhei 124,007 30 24.19 
Rezina 49,891 0 0.00 
Straseni 92,052 5 5.43 
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Soldanesti 40,942 0 0.00 
Telenesti 70,982 10 14.09 
Ungheni 116,705 6 5.14 
Southern areas 525,928 219 41.64 
Basarabeasca 27,997 1 3.57 
Cahul 124,091 32 25.79 
Cantemir 61,317 8 13.05 
Causeni 89,356 13 14.55 
Cimislia 58,604 3 5.12 
Leova 51,990 2 3.85 
Stefan-Voda 69,394 148 213.27 
Taraclia 43,179 12 27.79 
ATU Gagauzia 161,676 2 1.24 
Transnistria 468,414 54 11.53 
Total cases in cities 984,656 326 33.11 
Total cases in districts  2,558,052 585 22.87 
Total cases per Republic  3,542,708 965 27.24 
 
 
 
Figure 3. Distribution of COVID-19 cases depending on the living areas of the infected persons during 
the reference period in the Republic of Moldova (in %). 
 
The average age of those infected was 45.2 years; 
the mean age for COVID-19 infected people from 
urban areas was 44.6 years, while those from 
rural areas – 46.1 years. The mean age of COVID-
19 infected men was 42.9 (386 people) and in-
fected women – 46.7 years (575 people). 
According to gender distribution, 244 infected 
women and 141 infected men were from rural 
areas, which made up 63.4±2.5% vs. 36.6±2.5%, 
respectively. 316 COVID-19 infected women and 
223 men were from urban areas, accounting for 
58.6±2.1% vs. 41.4±2.1%, respectively. Thus, 
these data confirmed that gender distribution 
depending on the living environment presents a 
statistically significant difference (p≤0.05)        
(fig. 4). 
 
 
 
Figure 4. Gender distribution of infected persons depending on their living areas in the initial pandem-
ic stages in the Republic of Moldova (in %). 
 
Urban
Rural
36,6
41,4
38,3
63,4
58,6
61,7
0
10
20
30
40
50
60
70
Rural Urban Total
% Men Women
 
 
   10  
 
VOL. 2, ISSUE 2 
2020 
 
Out the total number of women, 11 women were 
found pregnant, which made up 1.9% of preg-
nancy cases. Furthermore, 2 people pregnant 
were reported as being in the first trimester 
(25%), 5 pregnant women were in the second 
trimester of pregnancy (62.5%), and only one 
woman was in the third trimester of gestation 
(12.5%). 
The study of age-related COVID-19 distribution 
showed that the most affected were people aged  
50-59 years, which included 232 cases, followed 
by people aged between 40-49 years found in 
170 COVID-19 cases. People aged 30-39 years 
were ranked third among total number, found in 
152 confirmed cases, followed by a small differ-
ence in-group of people aged 60-69 years, ac-
counting for 147 of infected cases. The least 
number of infected cases were reported in chil-
dren (0-9 years) with a total of 37 cases and in 
those older than 80 years, where only 6 cases 
were recorded (fig. 5). 
 
 
 
Figure 5.  Age distribution of COVID-19 cases recorded during the reference period in the Re-
public of Moldova (abs.). 
 
Another important epidemiological aspect in-
cluded within the study refers to people travel-
ing abroad in the last 14 days before the onset of 
disease. Therefore, the distribution of people 
who traveled abroad within 14 days before the 
onset of the disease was 20.2±1.6% (129 cases); 
those who did not travel abroad 79.8±1.6% (510 
cases); those who traveled or admitted to have 
been in contact with a confirmed case of COVID-
19 abroad – 22.7±4.0% (25 cases); 43.7±4.7% 
(48 cases) could not confirm or deny being in 
contact with infected people; 33.6±4.5% (37 
cases) stated that they were not in contact with a 
confirmed case of COVID-19 abroad (fig. 6).
 
 
 
Figure 6. Distribution of people traveling abroad and being in contact  
with confirmed COVID-19 cases (in %). 
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Of those who traveled abroad during the last 14 
days, most people were found to  return from the 
UK (33 people), followed by those who returned 
from Italy (21 cases), and from Ukraine (14 cas-
es), which are the most visited countries by Mol-
dovans for business or travelling purposes. Oth-
er countries included France – 13 cases, Russia – 
10, Romania 7, Dubai – 4, Czech Republic and 
Germany – per 2 cases each, Austria, Belarus, 
Bulgaria, Switzerland, Turkey – 1 case per each 
country. 18 epidemiological investigations did 
not reveal data upon the country visited by those 
who claimed to have traveled abroad. 
All people diagnosed with COVID-19 and who 
had not traveled abroad during the last 14 days 
(being considered as local transmission of infec-
tion) were asked about their contacts with al-
ready confirmed COVID-19 cases. Therefore, 
based on epidemiological surveys, it was found 
that 430 people were in contact with a confirmed 
case (54.3±2.0%), 164 people stated that they 
were not in contact with COVID-19 positive peo-
ple (20.7±1.5%) and 198 people did not know  
for sure (25.0±1.5%). Epidemiological data did 
not reveal any relevant information in 173 peo-
ple (fig. 7). 
 
 
 
Figure 7.  Distribution of cases that were in/no contact with people diagnosed with COVID -19 (in%). 
 
The Republic of Moldova, as well as other coun-
tries registered a number of SARS-CoV-2 – in-
fected health care workers. The HCWs were a 
subject of specific testing strategy, therefore 
some selection bias could influence the figures 
regarding the HCWs infection prevalence. The 
HCWs as general population have been tested in 
case of COVID-19 suspecting, when they were 
exposed to the risk in the health care facilities 
also when they were identified as being in con-
tact with a confirmed case. The local initial epi-
demic stage revealed that out of the total of 965 
infected people, 257 were healthcare workers, 
which made up 26.6±1.4% of cases. Out of these 
cases, 88 (34.2±3.0%) were nurses, 76 (9.6±  
2.8%) – auxiliary medical staff, 70 (27.2±2.8%) – 
doctors, 19 (7.4±1.6%) – first-aid men, 3 (1.2± 
0.7%) – pharmacists and a paramedic (0.4±  
0.4%)(fig. 8). 
 
 
 
Figure 8. Distribution of infected healthcare workers out of the total number of cases and distribution 
depending on their professional category (in%). 
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Most cases of infections among healthcare work-
ers were registered in Soroca – 86, Stefan Voda – 
46, Glodeni – 15, Republican Clinical Hospital 
(Chisinau) – 14, Emergency Hospital Chisinau – 
13, Clinical Psychiatric Hospital – 8, Orhei Dis-
trict Hospital – 7, National Center for Pre-
Hospital Emergency Medical Assistance – 6. Of 
those 37 (14.4±2.2%) healthcare workers had 
contracted the infection within medical institu-
tions, whereas the remaining 220 (85.6±2.2%) 
cases could not determine the path of transmis-
sion (fig. 9).  
 
 
 
Figure 9. Distribution of COVID-19 cases within medical institutions during the reference period (in %).  
 
Clinical manifestation of the diseases and health 
status of people diagnosed with COVID-19 have 
been assessed. Thus, it was established that on 
April 6, 2020 there were 77 (8.0±0.9%) people 
hospitalized with severe disease, 335 
(34.7±1.5%) people had a medium severe di-
sease, and 553 (57.3±1.6%) cases showed mild 
symptoms (fig. 10). 
 
 
 
Figure 10. Distribution of patient health status with COVID-19 in the initial epidemic period in the  
Republic of Moldova (in %). 
 
To date, the total number of people treated for 
COVID-19 is 40 (65.6±6.1%) and 21 (34.4±6.1%) 
people died. 904 (93.7±0.8%) cases are active 
and 6.3±0.8% are closed cases (deceased, dis-
charged) (fig. 11). 
 
 
 
Figure 11. Distribution of closed cases and their classification in the initial COVID-19 epidemic period 
in the Republic of Moldova (in %). 
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DISCUSSIONS 
The epidemiological situation in the Republic of 
Moldova has evolved following WHO well-known 
scenarios: ”zero”, imported cases, clusters and 
community transmission. The first COVID-19 
case, which was confirmed on 8 March 2020, did 
not surprisingly occur. Furthermore, the infec-
tion transmitted among people through close 
contact, including family members. Clusters and 
later community transmission were registered. 
The present study findings are similar to other 
studies that found a higher percentage of infect-
ed people in urban living environment. Thus, Fan 
J. et al. (17) found that in China's Gansu Province, 
the share of urban COVID-19 infected people was 
58.3%. The same findings were reported by a-
nother study conducted in China in Tianjin Prov-
ince by Cao C et al. (18) that determined COVID-
19 infection in 52.4% of cases from urban areas 
and in suburban, whereas 47.6% cases were 
from  rural areas.  These findings as well as those 
of the present study can be explained by the fact 
that SARS-CoV-2 is more easily spread in urban 
areas due to higher population density, closer 
contact between subjects and less social distanc-
ing compared to rural living environment.  
Regarding the age of patients with COVID-19 in 
the initial period, studies in outbreaks in China 
found that in Gansu Province, the patients identi-
fied in the early period were younger than those 
identified in the late period, but in general 54 of 
patients were younger (mean age 38 years) than 
patients identified in the early stage of the out-
break in Wuhan (mean age 59 years) (4). In this 
context, the mean age of 45.2 years was recorded 
in the early period of the COVID-19 epidemic in 
the Republic of Moldova, which tends to resem-
ble the indices recorded in other (secondary) 
outbreaks, other than the initial one in the Chi-
nese city of Wuhan. By assumption, COVID-19 
have been registered among middle age group, 
because cases at the beginning of pandemic have 
been mainly imported, and represent middle-age 
people who are working abroad with following 
transmission of the virus among their family 
members, In the study of Fan J. (17) the distribu-
tion of the disease by sex did not differ signifi-
cantly between the early and late periods, but 
number of female patients slightly predominat-
ed. In contrast, Chen and colleagues reported 
more men than female patients in the Wuhan 
outbreak (19). Cao C. and co-workers also re-
ported higher prevalence of infection in men in 
their Tianjin study, accounting for 51.64% and 
women in 48.06% (18). In the context of these 
confusing data, it is still premature to interpret 
the obtained study data where the COVID-19 
incidence in women is obviously higher than in 
men. 
As regarding the most affected age group, almost 
all the studies showed that middle-aged people 
were the most affected, especially those aged 40-
49 years, followed by people aged 50-59 (17, 18, 
19). It could be assumed that this is associated 
with people migration particularly in Italy and 
Great Britain, middle-aged females being the 
most affected ones. The study conducted during 
the reference period revealed a tendency of in-
creasing COVID-19-associated morbidity in peo-
ple aged 50-59 years. However, further addition-
al information is required to trace out final con-
clusions. 
As regarding the population travelling, different 
studies divide information into the early epidem-
ic stages of travelling to China and the later stag-
es of the COVID-19 pandemic. Studies have 
drawn particular attention to the citizens who 
returned from the so-called "red zones" or coun-
tries with a large number of confirmed COVID-19 
cases. Thus, according to Hien Lau et al. (20), 
51.89% of those interviewed traveled to China in 
the initial stage and 28.26% travelled to other 
countries in the second stage. These data corre-
spond to our study findings, where 20.2% of 
people reported travelling abroad in the last 14 
days. The significant difference between the 
number of people who traveled to China in the 
initial pandemic stage and those who traveled to 
other countries during the second stage can be 
explained by an increase in number of cases of 
local (community) SARS-CoV-2 transmission. 
An important feature of COVID-19 pandemic is 
the infection spread among healthcare workers, 
particularly of first-line medical assistance.  A 
series of studies have been referred to this phe-
nomenon, showing different incidence among 
infected healthcare workers. Thus, in the USA, 
the state of Ohio reported at least 16% of cases 
involving healthcare workers, while in Minneso-
ta, this index was 28% (21) In the province of 
Brescia, the central outbreak in Italy, 10-15% of 
doctors and nurses were infected during the 
initial period of the pandemic (22). Subsequent-
ly, it appears  that  the   share of infected  health- 
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care workers in Italy has increased to 20% (23). 
Spain reported the latest figures for infected 
healthcare workers on March 30. At that time, 
around 12 thousand of healthcare workers were 
estimated to be infected, out of over 85 thousand 
cases, i.e. the incidence rate being of 14% (24). 
In Romania, the last official and valid report was 
made on April 3. By that time, 474 doctors and 
other medical staff were infected in the neigh-
boring country, out of a total 3,183 cases, the 
incidence rate being of 14.8%. It should be noted 
that 318 cases were reported within a hospital in 
Suceava. On March 30, the incidence rate was 
14.5% (25). Compared to these data, our study 
revealed that the percentage of COVID-19 – con-
firmed cases among healthcare workers ac-
counted for 26.6±1.4%. 
Therefore, there is a great difference in the inci-
dence of infected healthcare workers across the 
countries worldwide due to economic and socio-
cultural differences, access to protective equip-
ment, medical staff training and compliance to 
preventive and control measures etc. 
As regarding the clinical aspects of COVID-19 
infection worldwide, particularly of patient’s 
condition, 4% of cases were reported as severe, 
followed by milder or moderate severity level 
(26). If compared to this index from the Republic 
of Moldova, our study revealed 8% of patients 
with severe clinical evolution; therefore, all sus-
pected cases were admitted to the hospital. 
However, due to the differences among counties 
regarding hospitals admission criteria as well as 
assigning of the severity of cases it is difficult to 
affirm that there were any specific issues regard-
ing the higher diseases’ severity. Another indica-
tor evaluated at this stage was the share of 
closed cases. The global indicator is 32.03% 
compared to 6.3% of closed cases from the Re-
public of Moldova. This gap is probably due to 
the late onset of the pandemic in the Republic of 
Moldova, considering that the recovery period of 
patients with COVID-19 lasts up to a month, 
however, it might vary, depending on the clinical 
form and manifestations. There are also great 
concerns regarding the high rate of lethal cases 
among patients in the Republic of Moldova – 
34.4% compared to 21.0% worldwide, thus im-
plicitly displaying a lower rate of discharged 
patients from Moldova – 65.6% compared by 
79.0% globally (26). 
CONCLUSIONS 
1. The first month of COVID-19 epidemic exhibited a dynamic evolution, showing an increasing ten-
dency to affect all the administrative territories of the Republic of Moldova.  
2. The most COVID-19 affected age groups in the Republic of Moldova correspond to those from the 
other countries worldwide, thus, the prevailing female infected cases made up 63.4±2.5%, then 
people living in urban areas – 58.3±1.6%, the mean age of people was 45.2 years, with a tendency 
to increase among people aged up to 70 years. 
3. The high rate of infected health care workers accounted for 26.6±1.4%, which was relat ively higher, 
compared to other states, where this indicator was as following: Spain – 14.0%, Romania – 14.8%, 
Italy 20.0%. 
4. The incidence of severe clinical forms, which required assisted ventilation, was higher in the Repub-
lic of Moldova compared to this index worldwide, thus being of 8% compared to 4% in other coun-
tries. Additional clinical resource management and practices are needed. 
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